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Pain-related Somato Sensory Evoked
Potentials: a potential new tool to improve
the prognostic prediction of coma after
cardiac arrest
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Abstract
Introduction: Early prediction of a good outcome in comatose patients after cardiac arrest still remains an
unsolved problem. The main aim of the present study was to examine the accuracy of middle-latency SSEP
triggered by a painful electrical stimulation on median nerves to predict a favorable outcome.
Methods: No- and low-flow times, pupillary reflex, Glasgow motor score and biochemical data were evaluated at
ICU admission. The following were considered within 72 h of cardiac arrest: highest creatinine value, hyperthermia
occurrence, EEG, SSEP at low- (10 mA) and high-intensity (50 mA) stimulation, and blood pressure reactivity to
50 mA. Intensive care treatments were also considered. Data were compared to survival, consciousness recovery
and 6-month CPC (Cerebral Performance Category).
Results: Pupillary reflex and EEG were statistically significant in predicting survival; the absence of blood pressure reactivity
seems to predict brain death within 7 days of cardiac arrest. Middle- and short-latency SSEP were statistically significant in
predicting consciousness recovery, and middle-latency SSEP was statistically significant in predicting 6-month CPC outcome.
The prognostic capability of 50 mA middle-latency-SSEP was demonstrated to occur earlier than that of EEG reactivity.
Conclusions: Neurophysiological evaluation constitutes the key to early information about the neurological
prognostication of postanoxic coma. In particular, the presence of 50 mA middle-latency SSEP seems to be an early
and reliable predictor of good neurological outcome, and its absence constitutes a marker of poor prognosis.
Moreover, the absence 50 mA blood pressure reactivity seems to identify patients evolving towards the brain death.
Introduction
Several efforts have been recently made to improve prog-
nostication in comatose patients after cardiac arrest (CA).
While the introduction of targeted temperature manage-
ment (TTM) issues new challenges in interpreting clinical
and neurophysiological findings [1–5], early prediction of a
good outcome still remains an unsolved question. A multi-
modal approach combining clinical, biochemical, neuro-
physiological, and neuroimaging parameters was proposed
to overcome the prognostic failure induced by TTM [6],
but it strengthened the accuracy only in predicting a poor
outcome. Conversely, recent trials suggested the detection
of continuous, reactive, spontaneous brain cortical activity
to predict a good outcome [6–8], but unfortunately elec-
troencephalogram (EEG) findings can suffer both from
false positives and false negatives, reflecting the dynamism
of acute brain damage, which can evolve toward the re-
covery from brain ischemia or toward worsening damage.
False positive EEG finding (i.e., postanoxic status epilepti-
cus in a patient who then recovers) are of critical value for
the prognostication because they may discourage physi-
cians from intensifying treatments [9, 10]. Literature
shows that in the acute phase after CA, the brain ischemia
associated with hypothermia and pharmacological
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sedation may suppress reactivity and the cortical synaptic
background transmission at different levels, hiding the ex-
istence of still-viable brain tissue but not functioning in a
way that is typical of the ischemic penumbra [11–15].
How can the diagnostic tools in the early phase of posta-
noxic coma be improved? Neurophysiologists and neuro-
critical care physicians have recently shown interest in
middle-latency somato sensory evoked potentials (ML-
SSEP), represented by cortical potentials in the range of
40–70 ms, because they reflect higher-order brain pro-
cesses represented by cortical-cortical synaptic functions
[16–19]. These synaptic functions seem to be required for
recovery of consciousness and a good outcome [20–23]. It
has also been attested that ML-SSEPs are more sensitive
than short-latency SSEP (SL-SSEP, commonly named
N20/P25) to the ischemic injury, and their preservation
reflects a lower level of brain damage [24–26].
Furthermore, past studies showed that 40–70 ms poten-
tials are localized in the para-Sylvian cortex near the lateral
sulcus by the firing of the secondary somatosensory area
(SII) and insula [27], that they can be activated by A delta
nerve fibers [28, 29], and that they are involved in the cor-
tical representation of pain [30]. Several years later we had
the opportunity to replicate the causal effect of A delta
conduction fiber on ML-SSEP generation; indeed, we sup-
pressed 40–70 ms potentials triggered by painful stimulus
at 50 mA by blocking the median nerve sulcus with local
anesthesia [11]. Moreover, we found that 50 mA ML-SSEP
stimulation on the median nerves in anesthetized patients
is associated with an increase in blood pressure, suggesting
an autonomic response to stress [11, 31]. In a preliminary
report on a small cohort of postanoxic comatose patients,
we showed that ML-SSEP and blood pressure (BP) reactiv-
ity triggered by painful electrical stimulations on the me-
dian nerves seem to predict, respectively, a good
neurological outcome and survival [31]. Finally we attested
that the same stimulation paradigm applied to functional
magnetic resonance imaging (fMRI) can show the brain
network involved in the detection of pain, also called the
“pain matrix”: SII, insula, and anterior cingulate cortex
[32]. Prognostically, the presence of this neurophysiological
cortical activity (and the respective neuroanatomical activ-
ity) demonstrates the functional integrity of a network that
is multisensory, non-nociceptive-specific, and involved in
the processing of salient sensory input related to motor
preparation and emotional expression [33, 34]. In other
words, in postanoxic coma, the persistence of ML-SSEPs
after SL-SSEP reflects the functional integrity of connec-
tions that are involved in more complex processes than
those of the primary somatosensory cortex (which are de-
tected by SL-SSEPs). On the other hand, the absence of
ML-SSEPs after SL-SSEP means that those areas involved
in consciousness recovery lack functionality, thus predict-
ing an evolution toward the minimally conscious state [32].
The target of this study is to compare ML-SSEP and
BP reactivity triggered by high-intensity stimulation on
the median nerves to all the most important clinical, bio-
chemical and neurophysiological parameters that litera-
ture attests as early predictors of survival, consciousness
recovery and good neurological outcome (i.e., awakening
and Glasgow-Pittsburgh cerebral performance categories
(CPC) 1–2).
Methods
Subjects
From July 2010 to August 2014, 167 postanoxic patients
were admitted to ICUs at Treviso Regional Hospital
(103 in the general ICU and 64 in the cardiac surgery
ICU). As the major inclusion criterion for the present
study was the availability of the EEG and SSEP within
72 h of CA, only 46 patients were retrospectively consid-
ered. All the neurophysiological evaluations were perfor-
med by the same neurophysiologist. None of these
patients had previous neurological disease or sepsis. No
distinction in recruitment was made for the place (in-hos-
pital or out of hospital) or cause (cardiac or non-cardiac)
of CA. The Lund University CA system (LUCAS) was
used as a bridge for extracorporeal membrane oxygen-
ation (ECMO) in patients not achieving the return of
spontaneous circulation (ROSC) with conventional car-
diopulmonary resuscitation (CPR). After ICU admission,
patients were evaluated and subjected to TTM with Arctic
Sun© 5000 (Medivance, Inc. 321 South Taylor Ave. Suite
200, Louisville, CO 80027), according to protocols de-
scribed in the literature [35].
Clinical and biochemical parameters
Time from CA to ROSC was divided into no-flow (time
from CA to CPR) and low-flow (time from CPR to
ROSC or to the start of ECMO). The initial CA rhythm
was categorized into ventricular tachycardia (VT),
ventricular fibrillation (VF), pulseless electrical activity
(PEA) and asystole (AS). Pupillary reflex (PR) and the
Glasgow scale motor score (M) were measured by the
intensive care physician at ICU admission. First values
of partial pressure of arterial oxygen (PaO2), partial
pressure of arterial carbon dioxide (PaCO2), HCO3
−,
pH, glucose and lactates at hospital admission were
considered.
The occurrence of hyperthermia (tympanic tempe-
rature >37.8 °C) and the highest value of creatinine
within 72 h of CA were also reported. Patients requiring
pharmacological cardiovascular support were catego-
rized according to three levels: low dosage (dopamine
or dobutamine ≤4 μg·kg−1·min−1, noradrenaline (nor-
epinephrine) ≤0.1 μg·kg−1·min−1, or adrenaline (epi-
nephrine) ≤0.05 μg·kg−1·min−1), medium dosage
(dopamine or dobutamine >4−1 and <8 μg·kg−1·min−1,
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noradrenaline >0.1 μg·kg−1·min−1 and <0.2 μg·kg−1·min−1,
or adrenaline >0.05 μg·kg−1·min−1 and <0.1 μg·kg−1·min−1)
and high dosage (dopamine or dobutamine ≥8 μg·kg
−1·min−1, noradrenaline ≥0.2 μg·kg−1·min−1, or adrenaline
≥0.1 μg·kg−1·min−1).
Neurophysiological evaluation
Neurophysiological recordings were performed within
72 h after CA (at a mean of 33 ± 22 h) and consisted of
EEG (background pattern and reactivity) and SSEP re-
corded in the same session. SSEP was performed by bilat-
eral stimulation of the median nerves at 3.3 Hz using
needle electrodes on both wrists. We considered two steps
of electrical stimulation - low intensity (10 mA) and high
intensity (50 mA) - to trigger the possible appearance of
unilateral or bilateral cortical ML-SSEP. SL-SSEP was de-
fined as present if the cortical N20/P25 response was
present on one or both sides. SL-SSEP was defined as bi-
laterally absent if no reproducible potentials could be
identified on either side at a maximum gain of 1 uV per
division in the presence of the brachial plexus potential.
ML-SSEP was considered present if any reproducible po-
tentials were detected on one or both sides in the range of
30–90 ms and with amplitude over 0.5 uV. Both SL and
ML-SSEP were considered in the same recording window
of 100 ms. The high-intensity stimulation was also used to
trigger EEG and BP reactivity. BP reactivity was consid-
ered significant if there was an increase of 10 % over base-
line values recorded at 10 mA stimulation. Muscle-
paralyzing medication (cisatracurium, 0.15 mg·kg−1) was
always used during the neurophysiological evaluation to
reduce the noise induced by possible muscle artifacts. The
ground electrode was placed on the left shoulder for both
EEG and SSEP recordings. The impedance was kept below
1 kΩ. EEG and SSEP were recorded using the NIM-
Eclipse© Nerve Monitoring System (Medtronic Xomed,
Jacksonville, FL, USA).
EEG recording parameters and classification
Eight bipolar EEG channels were recorded with needle
electrodes placed at the standard scalp sites (F3/F4-Cz,
C3’/C4’-Cz, T3/T4-Cz, P3/P4-Cz); in particular, C3’ and
C4’ were placed 2 cm posterior to C3 and C4, according
to the 10/20 international system. The EEG recording
parameters were 1 and 40 Hz for low- and high-
frequency filters, respectively, with a sampling rate of
250 Hz and hardware bandwidth of 1–100 Hz. EEG pat-
terns were categorized by simplifying Cloostermans’
classification [7] into three grades: grade 1, continuous
pattern (diffuse slowing, normal); grade 2, epileptiform
pattern; and grade 3, discontinuous pattern (isoelectric,
burst suppression, low voltage). We chose this simplified
EEG classification for statistical reasons and also because,
in our opinion, it is easily interpreted by intensivists. EEG
reactivity was considered if background patterns showed
any reproducible change (acceleration or slowing, includ-
ing amplitude variation) upon stimulation at 50 mA.
SSEP recording parameters
Four bilateral SSEP channels were recorded within a
time base of 100 ms: C4’/C3’–Fpz detected the SL (N20/
P25)-SSEP and the ML-SSEP; C4’/C3’–right Erb’s point/
left Erb’s point detected the interpeak between P14/N18
subcortical potential; Cv–Fpz detected the N13 cervical
potential; and right Erb’s point/left Erb’s point–Fpz de-
tected the N9 brachial plexus potential. SSEP was double-
filtered at 30 Hz and 500 Hz, respectively for low and high
frequency filter. Each trace averaged 100 sweeps; a mini-
mum of three traces were taken during every step. Each
step of stimulation lasted 90 s after rejection of trials due
to possible artifacts. The stimulus duration was length-
ened from 200 μs in the first series of 17 patients [29] to
1000 μs in the remaining patients to increase the possible
activation of the Aδ nerve fibers [36, 37].
Outcome evaluation
Recovery of consciousness was defined as the ability
to repeatedly carry out simple commands to more
than one physician. CPC outcome evaluation was per-
formed at 6 months after a medical and neurological
examination; in the same session, patients were sub-
jected to a neuropsychological evaluation, the results
of which were not considered for the following study.
Outcome was classified as good (CPC 1–2, corresponding
to no or moderate neurological disability), and poor (CPC
3–4–5, corresponding to a severe disability, coma and
death).
Decision to treat
Status epilepticus with normal SL-SSEP was treated only
after the neurophysiological evaluation, using incremen-
tal doses of midazolam (0.03–0.2 mg·kg−1·h−1) with or
without propofol (3–10 mg·kg−1·h−1); the most resistant
patients were additionally treated with thiopental to
achieve the burst suppression pattern for 48 h. Leveti-
racetam (1 g twice daily) was also used to replace con-
tinuous sedation; additional antiepileptic medications
were given according to EEG patterns. In patients with
bilaterally absent cortical SSEP, malignant unreactive
EEG patterns and absent brainstem reflexes, the decision
to withdraw supportive care was taken at a physician’s
discretion. Patients who persisted in a comatose state for
more than 15 days despite the presence of SL-SSEP or
SL/ML-SSEP were subjected to brain fMRI with the
same stimulation paradigm of the pain-related SSEP to
endorse the evoked potential evaluation.
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Ethics
The use of pain is a paradox in the medical practice;
while, on one hand, it must be treated to reduce suffer-
ing and stress response, on the other hand, it is widely
used to explore consciousness in comatose patients. In-
deed, the intensivists use the Glasgow coma scale (GCS)
daily to investigate consciousness status [38]. Since
2010, our institution has replaced the use of GCS with
pain-related (50 mA) SSEP in postanoxic coma, as com-
pared to the GCS, SSEP requires less frequent painful
stimulations (at most two stimulations with a 180-s dur-
ation) in the first 72 h and represents a more sensitive
method to explore brain function (brain somatosensory
afferent pathway reactivity versus the efferent motor re-
sponse of the GCS, which is often blunted by sedation)
[31]. As pain is considered an unpleasant experience that
involves the conscious awareness of noxious sensations
[39], the painful somatic (GCS) or neurophatic (pain-re-
lated SSEP) stimulations seem to be ineffective during
deep coma, sedation and concomitant global disorders
of the EEG signals; none of the patients experience a
conscious awareness of noxious sensations. Moreover, in
some circumstances, the pain-related ML-SSEP associ-
ated with severe EEG disorders can induce the physician
to continue therapies instead of abandoning them. Rela-
tives of the patients were always made aware of the use
of this additional technique. All procedures performed
in this study was in accordance with the ethical stan-
dards of the institutional and/or national research com-
mittee and with the 1964 Helsinki declaration and its
later amendments or comparable ethical standards. For
this retrospective type of study formal consent is not
required. The manuscript was approved by the Provincial
Ethics Committee of Treviso (N. 11; record 852/14).
Statistical analysis
All recorded parameters were related to three outcome
categories (survival, recovery of consciousness, and CPC
at 6 months after CA) and divided into two outcome
levels (good outcome (CPC 1–2) and poor outcome
(CPC 3–5)). To describe the general characteristics of
the study population, absolute and relative frequencies
were calculated for qualitative data, and mean and
standard deviation were calculated for quantitative
values (Table 1). To estimate which variables are related
to mortality, recovery of consciousness, or 6-month
CPC outcomes, Pearson’s chi-square test was calculated
for qualitative data and the Mann–Whitney test was
calculated for quantitative data. To estimate whether
TTM and sedation were associated with EEG reactivity,
SL-SSEP and ML-SSEP, or BP reactivity, Student’s t test
was performed. The Wilcoxon signed-rank test was perfor-
med to evaluate whether there were significant differences
between 50 mA ML-SSEP, EEG reactivity appearance time,
and time of best motor response among patients who had
10 or 50 mA ML-SSEP or EEG reactivity. To investigate
whether the presence of unilateral or bilateral ML-SSEP is
associated with CPC, Pearson’s Chi-square test was cal-
culated. Relative risk (RR) was calculated to investigate the
efficacy of TTM, intra-aortic balloon pumps (IABPs),
ECMO, continuous veno-venous hemofiltration (CVVH),
coronarography, and inotropic drugs; among out-of-
hospital (OHCA) patients, the same test was used to deter-
mine if there were significant outcome differences for pa-
tients hospitalized in the general and cardiac surgery ICUs.
Given the large number of comparisons conducted on the
same data and the large number of variables analyzed, we
performed the Holm [40] correction for multiple compari-
sons, which is less conservative than the more frequently
used Bonferroni correction. A p value <0.05 was consid-
ered to be statistically significant. To investigate which var-
iables added significant predictive capacity, for each output
variable, we fitted a logistic regression model by selecting
relevant variables through a cross-validated stepwise
selection procedure. Given the small dataset and the
high co-linearity of many variables, we estimated the
logistic regression parameters using a bias-reduction
maximum-likelihood method [41, 42]. Leave-one-out
cross-validation was implemented at each step of the
forward selection procedure to choose the best set of
predictors for each output variable. Statistical analysis
was performed with IBM SPSS Statistics for Windows,
Version 19.0 (IBM Corp., Armonk, NY, USA) and
with R [43].
Results
Survival outcome
During hospitalization, 22 of 46 patients (48 %, 95 % CI
34.13–61.87 %) survived; all survivors had BP reactivity.
Of those patients who did not survive, 9 (9.57 %, 95 %
CI 10.65–33.18 %) had no BP reactivity and died within
7 days because of brain death; the other 15 patients
(32.61 %, 95 % CI 20.87–47.03 %) died because of extra-
neurological causes (Fig. 1).
Pearson’s chi-square test (corrected for multiple com-
parisons) attested that two variables were statistically
significant to predict a fatal outcome at 6 months:
pupillary reflex (p <0.005) and simplified EEG patterns
(p <0.05), as shown in Tables 2 and 3. None of the results
for analysis of the quantitative variables were statistically
significant once the p values were corrected for multiple
comparisons (p <0.05).
The results of the logistic regression model show that
the only relevant variable to predict a fatal outcome is
the PR (odds ratio 23.399). The receiver operator charac-
teristic (ROC) curve of such a model is plotted in the
first panel of Fig. 2, and the area under the ROC curve
(AUC) is 0.8371.
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Table 1 General characteristics of the population
Characteristic Arithmetic mean Value standard deviation Minimum–Maximum
Age (years) 59.37 14.43 20–89
Time no-flow (minutes) 7.67 26.03 4–110
Partial pressure of arterial O2 (mmHg) 138.86 112.44 25.8–539
Partial pressure of arterial CO2 (mmHg) 48.92 12.91 21.1–81.1
HCO3
- (mmol/L) 14.85 4.75 7–27.4
Ph 7.13 0.14 6.87–7.41
Glycemia (mg/dL) 307.15 97.84 114–627
Lactates (mmol/L) 9.87 4.05 2.4–20
Highest creatinine during 72 h (mg/dL) 1.84 1.12 0.64–4.8
Characteristic Absolute frequency Number Value relative frequency % CI 95 %
Ventricular fibrillation rhythm of cardiac arrest 32 69.57 55.20–80.92
Pulseless electrical activity rhythm of cardiac arrest 8 17.39 9.08–30.72
Asystole rhythm of cardiac arrest 6 13.04 6.12–25.66
Cardiac arrest due to cardiac cause 32 69.57 55.20–80.92
Cardiac arrest due to non-cardiac cause 14 30.43 19.08–44.80
Patients with out-of-hospital cardiac arrest 35 76.09 62.07–86.09
Patients with in-hospital cardiac arrest 11 23.91 13.91–37.93
LUCAS™ patients 11 23.91 13.91–37.93
Not LUCAS™ patients 35 76.09 62.07–86.09
General ICU patients 18 39.13 26.39–53.54
Heart surgery ICU patients 28 60.87 46.46–73.61
Low-dosage patient’s intravascular drug support 10 21.74 12.26–35.57
Medium-dosage patient’s intravascular drug support 9 19.57 10.65–33.18
High-dosage patient’s intravascular drug support 27 58.70 44.34–71.72
Patients with intra-aortic balloon pump 16 34.78 22.68–49.23
Patients with no intra-aortic balloon pump 30 65.22 50.77–77.32
Patients who had coronary angiography 28 60.87 46.46–73.61
Patients who did not have coronary angiography 18 39.13 26.39–53.54
Percutaneous transluminal coronary angioplasty/stent 12 26.09 15.60–40.26
No percutaneous transluminal coronary angioplasty/stent 34 73.91 59.74–84.40
Patients on continuous veno-venous hemofiltration 16 34.78 22.68–49.23
Patients not on continuous veno-venous hemofiltration 30 65.22 50.77–77.32
Patients on extracorporeal membrane oxygenation 8 17.39 9.08–30.72
Patients not on extracorporeal membrane oxygenation 38 82.61 69.28–90.92
Patients on target temperature management 23 50.00 36.12–63.88
Patients not on target temperature management 23 50.00 36.12–63.88
Patients on target temperature management in <2 h 7 30.43 15.60–50.86
Patients on target temperature management in >2 h 16 69.57 49.14–84.40
Temperature ≥37.8 after 24 ha 20 47.62 33.36–62.28
Temperature <37.8 after 24 ha 22 52.38 37.72–66.64
Pupillary reflex + a 24 57.14 42.20–70.88
Pupillary reflex –a 18 42.86 29.12–57.80
First evaluation of motor response≤M2 39 84.78 71.77–92.43
First evaluation of motor response >M2 7 15.22 7.57–28.23
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Table 1 General characteristics of the population (Continued)
Isoelectric electroencephalogram 10 21.74 12.26–35.57
Burst Suppression electroencephalogram 3 6.52 2.24–17.50
Low voltage electroencephalogram 4 8.70 3.44–20.33
Epileptiform electroencephalogram 8 17.39 9.08–30.72
Diffuse slowing electroencephalogram 17 36.96 24.53–51.40
Normal electroencephalogram 4 8.70 3.44–20.33
Discontinuous electroencephalogram patterns 17 36.96 24.53–51.40
Epileptiform electroencephalogram 8 17.39 9.08–30.72
Continuous electroencephalogram patterns 21 45.65 32.15–59.82
Electroencephalogram reactivity 10 21.74 12.26–35.57
Electroencephalogram unreactivity 36 78.26 64.43–78.26
Short-latency somatosensory evoked potentials + 29 63.04 48.60–75.47
Short-latency somatosensory evoked potentials − 17 36.96 24.53–51.40
10 mA Middle-latency somatosensory evoked potentials + 9 19.57 10.65–33.18
10 mA Middle-latency somatosensory evoked potentials − 37 80.43 66.82–89.35
50 mA Middle-latency somatosensory evoked potentials + 19 41.30 28.28–55.66
50 mA Middle-latency somatosensory evoked potentials − 27 58.70 44.34–71.72
50 mA Blood pressure reactivity + 37 80.43 66.82–89.35
50 mA Blood pressure reactivity –columns 9 19.57 10.65–33.18
Sedation during Neurophysiological recordings 22 52.38 37.72–40.26
Target temperature management during Neurophysiological
recordings
12 26.09 15.60–40.26
aMissing data for four patients. LUCAS Lund University cardiac arrest system
Fig. 1 Distribution of patients on the outcome levels (survival, recovery of consciousness (CR) and cerebral performance category (CPC)) based on
blood pressure reactivity (BP-R), short-latency somatosensory evoked potentials SL-SSEP and middle-latency SSEP (ML-SSEP). Of the patients, 6 with
SL-SSEP and without 50 mA ML-SSEP died because of heart failure (n = 2), sepsis (n = 2) or bronchopneumonia (n = 2); 6 patients with SL-SSEP and
50 mA ML-SSEP died because of cardiogenic shock (n = 3), septic shock (n = 1), pulmonary hemorrhage (n = 1) or multiple organ failure (n = 1)
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Recovery of consciousness outcome
A total of 15 patients (32.61 %, 95 % CI 20.87–47.03 %)
regained consciousness. All of them had SL-SSEP and
50 mA ML-SSEP; however, 2 of these 15 patients (13.33 %,
95 % CI 3.73–37.88 %) died during hospitalization because
of non-neurological causes (Fig. 1), and 1 patient (6.67 %,
95 % CI 1.19–29.82 %) had CPC 3 at 6 months. Of the 31
patients (87.10 %, 95 % CI 71.15–94.87 %) who did not
regain consciousness, 27 did not have 50 mA ML-SSEP;
the other 4 patients (12.90 %, 95 % CI 5.13–28.85 %) died
during hospitalization without recovery of consciousness
because of non-neurological causes (Fig. 1).
Pearson’s chi-square test (after Holm’s correction for
multiple comparisons) attested that two variables were sta-
tistically significant to predict recovery of consciousness:
50 mA ML-SSEP (p <0.001) and SL-SSEP (N20/P25;
Table 2 Statistically significant variables
Variable Significant outcome P value Sensitivity % CI 95 % Specificity % CI 95 % PPV % CI 95 % NPV % CI 95 %
Pupillary reflex Survival <0.005 76.19 52.83–91.69 90.48 69.58–98.55 88.89 65.25–98.30 79.17 57.84–92.79
Continuous
EEG patterns
Survival <0.05 70.83 48.91–87.33 63.64 40.67–82.76 68.00 46.50–85.01 66.67 43.04–85.35
Epileptiform
EEG pattern
Survival <0.05 91.67 72.96–98.73 27.27 10.80–50.22 57.89 40.83–73.68 75.00 35.05–96.07
Discontinuous
EEG patterns
Survival <0.05 62.50 40.60–81.16 90.91 70.80–98.62 88.24 63.52–98.20 68.97 49.17–84.68
ML-SSEP at
50 Ma
Consciousness
recovery
<0.001 87.10 70.15–96.29 100.00 78.03–100.00 100.00 87.11–100.00 78.95 54.43–93.82
SL-SSEP Consciousness
recovery
<0.05 54.84 36.04–72.67 100.00 78.03–100.00 100.00 80.33–100.00 51.72 32.54–70.54
ML-SSEP at
50 Ma
6 months CPC <0.005 79.41 62.09–91.26 100.00 73.35–100.00 100.00 87.11–100.00 63.16 38.38–83.65
PPV positive predictive value, NPV negative predictive value, EEG electroencephalogram, ML-SSEP middle-latency somatosensory evoked potentials, SL-SSEP
short-latency somatosensory evoked potentials, CPC cerebral performance category
Table 3 Significant parameters in the population categorized according to mortality, consciousness recovery and CPC at 6 months
Characteristic Survivors Non survivors P value*
Absolute frequency
Number
Relative
frequency %
CI 95 % Absolute frequency
number
Relative
frequency %
CI 95 %
Pupillary reflex + a 19 45.24 31.23–60.05 5 11.90 5.19–24.99 <0.005
Pupillary reflex –a 2 4.76 1.31–15.79 16 38.10 25.00–53.19
Discontinuous EEG
patterns
2 4.35 1.20–14.54 15 32.61 20.87–47.03 <0.05
Epileptiform EEG 6 13.04 6.12–25.66 2 4.35 1.20–14.54
Continuous EEG
patterns
14 30.43 19.08–44.80 7 15.22 7.57–28.23
Characteristic Consciousness recovery No consciousness recovery P value*
Absolute frequency
number
Relative
frequency %
CI 95 % Absolute frequency
number
Relative
frequency %
CI 95 %
SL-SSEP + 15 32.61 20.87–47.03 14 30.43 19.08–44.80 <0.05
SL-SSEP − 0 0.00 0.00–8.38 17 36.96 24.53–51.40
50 mA ML-SSEP + 15 32.61 20.87–47.03 4 8.70 3.44–20.33 <0.001
50 mA ML-SSEP − 0 0.00 0.00–8.38 27 58.70 44.34–71.72
Characteristic CPC 1–2 CPC 3–5 P value*
Absolute frequency
number
Relative
frequency %
CI 95 % Absolute frequency
number
Relative
frequency %
CI 95 %
50 mA ML-SSEP + 12 26.09 15.60–40.26 7 15.22 7.57–28.23 <0.005
50 mA ML-SSEP − 0 0.00 0.00–8.38 27 58.70 44.34–71.72
*P value with Holm correction. aMissing data for 4 patients. EEG electroencephalogram, ML-SSEP middle-latency somatosensory evoked potentials, SL-SSEP
short-latency somatosensory evoked potentials, CPC cerebral performance category
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p <0.05), as shown in Tables 2 and 3. The results from
the logistic regression model show that only 50 mA ML-
SSEP was relevant in predicting a poor outcome (odds
ratio 189.43). The ROC curve of such a model is plotted
in the second panel of Fig. 2, and the AUC was 0.9355.
CPC outcome
At 6 months, 12 of 46 patients (26.09 %, 95 % CI
15.60–40.26 %), that is, 12 of 13 (92.31 %, 95 % CI
66.69–98.63 %) patients who regained consciousness
and survived, had a CPC of 1 or 2. All of them had SL-
SSEP and 50 mA ML-SSEP. Of the 34 patients
(79.41 %, 95 % CI 63.20–89.65 %) who had CPC 3–5,
27 did not have 50 mA ML-SSEP; 6 of these 34 patients
(17.65 %, 95 % CI 8.35–33.52 %) had 50 mA ML-SSEP
but had CPC 5 because they died during hospitalization
(2 of them after recovery of consciousness); only 1 pa-
tient (2.94 %, 95 % CI 0.52–14.91 %) had 50 mA ML-
SSEP but had CPC 3 at 6 months - this patient regained
consciousness during hospitalization but ultimately
evolved into a minimally conscious state (Fig. 1). No
patient who was alive at ICU discharge died before the
6-month follow up.
Pearson’s chi-square test (after applying Holm’s correc-
tion for multiple comparisons) attested that only 50 mA
ML-SSEP was statistically significant (p <0.005) in pre-
dicting CPC (Tables 2 and 3). The results from the logis-
tic regression model show that only 50 mA ML-SSEP
was relevant in predicting CPC (odds ratio 91.65). The
ROC curve of such a model is plotted in the second
panel of Fig. 2, and the AUC was 0.8971.
Additional analysis
The time to the appearance of ML-SSEP was statisti-
cally lower than the time to the appearance of EEG
reactivity (22 ± 12 vs. 196 ± 78 h, respectively, p <0.005)
and was also lower than the time to the best Glasgow
motor score (266 ± 304 h, p <0.001). Sedation and TTM
did not influence the neurophysiological recordings. TTM
did not prevent hyperthermia within 72 h.
ML-SSEP distribution among the sample
Of the 19 patients who had ML-SSEP, 9 (47.37 %, 95 %
CI 27.33–68.29 %) showed ML-SSEP at both 10 and
50 mA, and 10 (52.63 %, 95 % CI 31.71–72.67 %) had
ML-SSEP only at 50 mA stimulation. The 9 patients
who presented with 10 mA ML-SSEP had bilateral
(n = 3), right (n = 3) and left (n = 3) ML-SSEP. The 10
patients who presented with only 50 mA ML-SSEP
had bilateral (n = 7), right (n = 2) and left (n = 1) ML-
SSEP. Pearson’ chi-square test attested that the pres-
ence of unilateral or bilateral ML-SSEP had no effect
on predicting 6-month CPC.
Discussion
This study suggests that the combination of a few neuro-
physiological and clinical parameters is useful to quickly
stratify the prognosis of coma after CA (33 ± 22 h). In
particular, PR and EEG patterns predict survival at
6 months, and the absence of BP reactivity seems to be
related to brain death within 1 week. SL-SSEP and
50 mA ML-SSEP predicted consciousness recovery, and
50 mA ML-SSEP predicted CPC outcome at 6 months.
The prognostic capability of 50 mA ML-SSEP occurred
earlier than that of EEG reactivity. All of these parame-
ters can be considered brain-damage-related indexes.
Our data also showed that soon after CA the GCS has
poor prognostic capability with respect to the neuro-
physiological parameters.
Fig. 2 Receiver operator characteristic (ROC) curves for the three final logistic models. First panel (left): pupillary reflex ROC curve for survival;
second panel (middle): 50 mA middle latency somatosensory evoked potentials (ML-SSEP) ROC curve for consciousness recovery; third panel
(right): 50 mA ML-SSEP ROC curve for the 6-month cerebral performance category
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We find it more useful to stratify the level of good out-
comes (in recovery of consciousness and CPC 1–2) at
6 months than to record only the best CPC score at any
time within the first 6 months after CA [7], as recovery
of consciousness reflects the end of coma caused by
lower anoxic injury. As 50 ML-SSEP can quickly detect
lower anoxic injury, it is important to focus therapies in
these patients who can regain consciousness and eventu-
ally have a CPC of 1–2. In other words, having ML-SSEP
does not necessarily imply a good outcome. A good out-
come could be primarily related to the concomitant path-
ologies. Indeed, in our series, among those with 50 mA
ML-SSEP, 7 patients did not have CPC of 1–2 at 6 months:
6 patients died during hospitalization (2 after recovery of
consciousness, see Fig. 1), and 1 regained consciousness
but had CPC 3 at 6 months - we suspect that this patient
suffered from untreated status epilepticus, because the
EEG reports during the rehabilitation time underlined a
poor quality of recording due to many supposed muscular
artifacts.
Predictors of survival
Our overall mortality rate is lower than the rates from
other recent series (48 %, vs. 70 % [44]), and is similar to
the rate in the 1950s [45]; this difference can be ex-
plained by considering neurophysiological decisions to
withdraw treatments in other trials [2, 6]. By contrast, in
our hospital, an increased number of patients survived
in a permanent vegetative state (PVS).
PR at ICU admission (recorded independently of
TTM) seems to be the only parameter related to survival
at 6 months, as the early absence of this brainstem reflex
suggests a deep impairment of the central nervous sys-
tem; however, this measure is less reliable than 72 h PR
(10 % FPR vs. 0–4 %) [2, 3]. Interestingly, an absence of
BP reactivity seems to constitute a marker of brain death
within 1 week (specificity 100 %). These data are in line
with Fugate’s [46] findings, in which the loss of cardio-
vascular regulation was related to brain death within one
week. Moreover, patients with BP reactivity and absent
PR who died after 1 week did so due to non-neurological
causes. Interestingly, BP reactivity and PR seem to be
related to the timing of death in our sample, probably be-
cause they are the expression of different levels of subcor-
tical dysfunction, in the brain stem and the midbrain,
respectively. We found, as shown in previous data [31],
that BP reactivity was useful to stratify prognosis among
patients with absent SL-SSEP into those who will die and
those who could survive with a poor outcome (CPC 4).
Predictors of consciousness recovery and CPC 1–2 at
6 months
Only SSEP evaluation was statistically significant in pre-
dicting recovery of consciousness and good CPC at
6 months. EEG was not statistically significant, but malig-
nant EEG patterns had good specificity (93 % for con-
sciousness and 100 % for CPC) in predicting a poor
outcome. Most of the patients who regained conscious-
ness (11 out of 15) and who had a good outcome (9 out of
12) had a continuous pattern, which is in line with the
findings of Cloostermans et al. [7] and Rossetti [2]. Preser-
vation of cortical synaptic transmission is the most critical
factor in early recovery; however, specificity is not high
(73 % for consciousness and 75 % for CPC), probably be-
cause of brain ischemia rather than TTM or sedation,
based on early (33 h from CA) recordings [9, 10, 13, 15].
Indeed, our data showed that TTM (33–34 °C) and sed-
ation did not change EEG and SSEP at all, reinforcing the
fact that the greatest determinant of brain dysfunction
both in intensive care [47] and in the operating room [48]
is brain ischemia. Moreover, hypnotic sedation (e.g.,
midazolam and propofol) does not attenuate pain-related
ML-SSEPs (like opioids do), as ML-SSEPs seem to be
the neurophysiological expression of the activation of
the brain-area network involved both in pain perception
[11, 32] and other salient sensory input [33].
We confirm the published data on SL-SSEP [49]:
absent N20/P25 relates to lack of conscious recovery
(100 % specificity) while present N20/P25 (SL-SSEP+) is
not sensitive enough (55 % and 50 %) to predict a good
neurological outcome. SSEP can explore both the primary
somatosensory cortex (by SL-SSEP) and the secondary
cortex (by ML-SSEP) in the range of 40–70 ms [17, 18].
ML-SSEP can be triggered by a 10 mA (9 patients) or
50 mA (19 patients) stimulus on median nerves. It is not
unusual that ML-SSEP can also be activated by a low-
intensity (10 mA) stimulus due to the salience of the elec-
trical stimulus, thus assuming a lower extension of brain
damage. However, 50 mA ML-SSEP has similar sensitivity
(87 % vs. 90 % and 79 % vs. 88 %) but higher specificity
(100 % vs. 40 % and 100 % vs. 42 %) than 10 mA ML-
SSEP in predicting recovery of consciousness and
CPC 1–2 at 6 months, respectively. Indeed, by stressing
(at 50 mA) the somatosensory system and activating pain
Aδ fibers, it is possible to explore the brain tissue that is
still viable but not functioning, favoring the appearance of
evoked cortical-cortical interactions (ML-SSEP) independ-
ent of the spontaneous cortical EEG reactivity, which is
often suppressed by the brain ischemic penumbra (Fig. 3).
In our opinion, in the early phase of the postanoxic
coma, the interpretation of SSEP reactivity seems to be
simpler and more effective than that of EEG reactivity.
Technical and procedural aspects
Muscle relaxant medication, which hides clinical evalu-
ation, is a fundamental prerequisite to improve the reli-
ability of neurophysiological evaluation by increasing the
signal-to-noise ratio [31, 32], as greater noise might
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increase the numbers of false positives [1, 18]. In this
study, false positives are minimized both by stimulation
on the median nerve by the needle electrodes and by the
earliness of the neurophysiological assessment (mean of
33 ± 22 h), which reduces the risk of technical difficulties
related to possible limb edema or sepsis [50]. Moreover,
the earliness of neurophysiological assessment prevents
the possible interference of deep sedative medications
like pentobarbital, which seems to suppress ML and
long-latency SSEP in patients with severe head injuries
[51]. However, experimental studies on recruitment of A
delta fibers, as related to the strength of electrical stimu-
lus applied on the peripheral nerve, show that pentobar-
bital does not suppress ML-SSEP [28, 52]. Our previous
experience showed that, in anesthetized patients, pro-
pofol and midazolam did not blunt the cortical reactivity
of electrical stimulation of A delta nerve fibers on the
median nerves [11]. Moreover, it is important to under-
line that, even if several studies have shown that a
stimulation rate above 1.5 Hz is associated with a de-
crease in ML-SSEP amplitude, the 50 mA stimulation
compensates for the suboptimal recording paradigm,
which consists of a 100 ms time base and a 3.3 Hz stimu-
lation rate [53, 54].
Finally, we considered electrical stimuli on the median
nerve sulcus to be a reproducible and noninvasive method
to activate the A delta nerve fibers for triggering evoked
and spontaneous brain reactivity; indeed this technique
provides a way to evaluate EEG reactivity simultaneously
with SSEP recording. Moreover the pain-related method-
ology is more sensitive to multimodal stimulations (som-
atosensory, auditory and visual), as these stimuli are under
the threshold of salience in patients with consciousness
disorders [55].
Fig. 3 Somatosensory evoked potentials (SSEP) recording at 12 h after cardiac arrest in patient 5 of our series who had consciousness recovery
and CPC 1–2. Upper: cortical SSEP (C3’/C4’–Fpz). Note the increase in amplitude and the decrease in latency of the N20/P25 evoked potentials at
50 mA electrical stimulation (red line) with respect to the baseline (black line) at 10 mA. Note also the appearance of ML-SSEPs (P55/N65 and P80/
N90) at 50 mA stimulation on the left median nerve (red line). Lower: 8-channel electroencephalogram (EEG) (F3/F4-Cz, C3’/C4’–Cz, T3/T4–Cz, P3/P4–Cz)
performed in the same session of SSEP. No significant background EEG pattern change is detected between baseline recordings (black lines) with
respect to the stimulation at 50 mA (red lines)
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Multimodal neurophysiological prediction of neurological
outcome
From a neurophysiological point of view, simplified EEG
patterns, SSEP (both SL and ML), PR, and BP reactivity
constitute the key parameters that can quickly (within 72 h
of CA) inform the prognostication of postanoxic coma be-
cause they are differently altered by ischemic injury with a
cranio-caudal encephalic direction. Indeed, the finding of a
normal or diffuse slowing EEG in the acute phase assumes
the integrity of the brain structures that generate the spon-
taneous and evoked activity. While a benign reactive EEG
pattern seems to be associated with 50 mA ML-SSEP (ex-
cept for the presence of a neurological disease that alters
the peripheral or central nerve transmission), 50 mA ML-
SSEP seems to not always be associated with a benign
reactive EEG pattern, as this pattern can appear later. The
fact that EEG can be more suppressed than SSEP by hyp-
oxic insult [56], hypothermia and anesthesia [11–15] shows
that these neurophysiological examinations investigate
different levels of brain function. Indeed, summed post-
synaptic potentials (which generate EEG patterns) depend
much more on the oxygen supply than do thalamus
cortical cells (which generate cortical SL-SSEP) [56]. To
supplement this work, our data showed that ML-SSEP trig-
gered by painful stimulation at 50 mA occurs much earlier
than a benign and reactive EEG does. In other words, the
50 mA ML-SSEPs stress the firing of the cortico-cortical
interactions involved in pain perception (in the insula, SII,
and cingulate cortex) independently of the spontaneous
cortical activity hidden by the ischemic penumbra. In this
way ML-SSEP seems to represent a higher-order complex-
ity of the somatosensory afferent pathway sensing mode,
and the recovery of normal spontaneous synaptic functions
seems to be critical in the recovery of the sending mode
through the efferent behavioral pathway. The reliability of
50 mA ML-SSEP in predicting preserved cortical con-
nections is also confirmed by fMRI neuroimaging data.
Patients who regained consciousness and had a good out-
come showed the activation of brain areas involved in the
detection of pain [32], as shown in Fig. 4, which represents
the twelfth patient of our series.
Interestingly, the early absence of ML-SSEP after
CA is a marker of EEG synaptic depletion associated
with insufficient recovery of motor-behavioral func-
tion and an evolution towards a minimally conscious
state [31, 32].
Fig. 4 Functional magnetic resonance imaging (fMRI) (21 days after cardiac arrest (CA)) of patient 12 of our series who had a good outcome,
showing the brain activation of the somatosensory, motor, premotor, left insula and cerebellum areas. Some artifacts are also visible. The
neurophysiological recording performed at 24 h after CA showed pain-related somatosensory evoked potentials (ML-SSEP) and a diffuse, slowing,
nonreactive electroencephalogram (EEG). The subsequent EEG patterns were characterized by epilectiform activity. This patient regained
consciousness at 33 days after CA
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Limitations
This study has some important limitations. First, the
neurophysiologist reading the ML-SSEPs (and EEG) was
not blinded to the patients’ clinical status and outcomes.
A multicenter prospective study should be carried out in
order to share and validate this methodology and fully
estimate the effectiveness of 50 mA ML-SSEP in predict-
ing neurological outcome in postanoxic patients. Further
analysis should also consider ML-SSEP amplitude and
laterality to better define long-term outcome and cogni-
tive status while using a more detailed scale than CPC
(e.g., Level of Cognitive Function, Coma Recovery Scale-
Revised or neuropsychological evaluation). Moreover, we
believe that the pain-related SSEP method could have
false positive results if the patient suffers from A delta
fibers disease. Finally, the impact of rehabilitation treat-
ments on the final outcome of the patients should be
evaluated.
Conclusions
This study shows that the combination of BP reactivity,
PR, simplified EEG, SL-SSEP, and ML-SSEP constitute
the key parameters that can quickly (within 72 h of CA)
inform the prognostication of coma after CA. The Glas-
gow neurophysiological analog, obtained through the ac-
tivation of ML cortical potentials with painful electrical
stimulation on the median nerves, seems to detect the re-
sidual higher-order brain processing function. This pre-
dicts a good neurological prognosis earlier than EEG
reactivity because this last one reflects the spontaneous
electrical activity of brain areas that can be stunned by
brain ischemia. Conversely, the absence of ML-SSEPs
seems to be associated with a bad outcome. According to
our opinion this method should be integrated into routine
neurophysiological evaluation and used to funnel ICU
treatments to patients with a good chance of recovery.
Key messages
 EEG, pupillary reflex, short- and middle-latency
SSEP, and blood pressure reactivity constitute key
parameters that can quickly (within 72 h of CA)
inform the prognostication of postanoxic coma
 Middle-latency pain-related SSEPs detected early
after a CA are associated with a good neurological
prognosis in the absence of concomitant
extra-neurological pathologies
 The prognostic capability of pain-related
middle-latency SSEP was demonstrated to occur
earlier than that of EEG reactivity
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